• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
73,918.76 394.50
( 0.54%)
Global Indices
Nasdaq
50,812.84 -74.94
(-0.15%)
Dow Jones
7,426.81 22.07
(0.30%)
Hang Seng
65,160.26 1,135.66
(1.77%)
Nikkei 225
10,368.25 0.20
(0.00%)
Forex
USD-INR
95.22 -0.51
(-0.53%)
EUR-INR
109.67 -1.54
(-1.39%)
GBP-INR
126.98 -1.60
(-1.25%)
JPY-INR
0.59 0.00
(-0.77%)

EQUITY - MARKET SCREENER

Sun Pharmaceutical Industries Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
524715
INE044A01036
93.2373503
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
SUNPHARMA
142.97
429145.05
EPS(TTM)
Face Value()
Div & Yield %
12.51
1
0.89
 

grp ltd
Tilak Ventures standalone net profit rises 151.63% in the March 2026 quarter
May 21,2026
Net profit of Tilak Ventures rose 151.63% to Rs 3.85 crore in the quarter ended March 2026 as against Rs 1.53 crore during the previous quarter ended March 2025. Sales rose 120.09% to Rs 14.02 crore in the quarter ended March 2026 as against Rs 6.37 crore during the previous quarter ended March 2025.

For the full year,net profit rose 53.43% to Rs 9.62 crore in the year ended March 2026 as against Rs 6.27 crore during the previous year ended March 2025. Sales rose 43.67% to Rs 30.43 crore in the year ended March 2026 as against Rs 21.18 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales14.026.37 120 30.4321.18 44
OPM %49.0018.52 -27.6717.33 -
PBDT5.742.43 136 13.698.53 60
PBT5.742.43 136 13.688.52 61
NP3.851.53 152 9.626.27 53